Australia, Nov. 10 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Effectiveness and safety of the Novel MiniMed Experimental Automated Insulin Delivery (NMX8-AID) System in Combination with Semaglutide in Young People with Type 1 Diabetes’. The following are the other relevant details related to the trial:
Trial ID: 391981
Submit Date: 6/30/26 13:33
Study Type: Interventional
Intervention: This is a single site and single arm clinical trial with an expected duration of an individual's study participation of 38 weeks. Enrollment will be staggered by age groups, with adults (aged 18 to 25 years) starting first, followed by adolescents aged 12 to 17 years. Two weeks of part...